U.S. Financials: Catch a Falling Knife?
Despite low valuations, U.S. financial stocks will likely remain a “value trap” until greater clarity emerges as to the ultimate magnitude of losses facing the financial system.
Despite low valuations, U.S. financial stocks will likely remain a “value trap” until greater clarity emerges as to the ultimate magnitude of losses facing the financial system.
A summary of our views on the questions and issues which those responsible for managing an endowment must resolve if they are to invest the assets effectively.
After years of supporting share prices and EPS growth with increasingly aggressive share-repurchase programs, companies are showing signs of buyback fatigue.
Six years into the commodity boom, and despite increasing risk factors, there remains a strong rationale for a properly conceptualized and managed portfolio allocation to commodities.
While a large segment of the U.K. equity market is exposed to direct of knock-on effects of house price declines, this is not reflected in current prices.
A closer look at “quality” equities across developed markets reaffirms our view that high-quality equities remain attractive and portfolios should remain tilted toward mega-cap growth.
The European Central Bank has been far less hawkish than advertised; as a result, Eurozone prices may rise faster than most expect.
While markets may rally over the coming months, the hurricane of deleveraging is far from over, with a second wave of turmoil likely as a weakening U.S. economy weighs on growth in the rest of the world, a scenario still not fully priced into equity markets.
While the Fed is committed to a policy of reflation, market conditions pose significant obstacles to success and there are also serious inflationary risks associated with this policy.
Deleveraging, insurance woes, and liquidity concerns deliver pitfalls and opportunities to taxable investors.